Application 220121
- Type
- ANDA
- Sponsor
- BIOCON PHARMA LIMITED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | CABOZANTINIB | CABOZANTINIB | TABLET | 20MG | No | No |
| 003 | CABOZANTINIB | CABOZANTINIB | TABLET | 40MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CABOMETYX | CABOZANTINIB | Exelixis, Inc. | 3850cce2-6137-42e5-a792-d318c4a4b3b5 | 2025-10-19 | Warnings, Adverse reactions | CABOZANTINIB |
| COMETRIQ | CABOZANTINIB | Exelixis, Inc. | 1a0c3bea-c87b-4d25-bb44-5f0174da6b34 | 2025-10-18 | Warnings, Adverse reactions | CABOZANTINIB |